Browsing by Author "Meitinger, Thomas (57215631099)"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Exome sequencing in individuals with congenital anomalies of the kidney and urinary tract (CAKUT): a single-center experience(2023) ;Riedhammer, Korbinian M. (57200625458) ;Ćomić, Jasmina (57896737200) ;Tasic, Velibor (7003911066) ;Putnik, Jovana (14008113300) ;Abazi-Emini, Nora (57896737400) ;Paripovic, Aleksandra (35311948800) ;Stajic, Natasa (6602606131) ;Meitinger, Thomas (57215631099) ;Nushi-Stavileci, Valbona (57193881397) ;Berutti, Riccardo (24483074500) ;Braunisch, Matthias C. (57192699344)Hoefele, Julia (57196082805)Individuals with congenital anomalies of the kidney and urinary tract (CAKUT) show a broad spectrum of malformations. CAKUT can occur in an isolated fashion or as part of a syndromic disorder and can lead to end-stage kidney failure. A monogenic cause can be identified in ~12% of affected individuals. This study investigated a single-center CAKUT cohort analyzed by exome sequencing (ES). Emphasis was placed on the question whether diagnostic yield differs between certain CAKUT phenotypes (e.g., bilateral kidney affection, unilateral kidney affection or only urinary tract affection). 86 unrelated individuals with CAKUT were categorized according to their phenotype and analyzed by ES to identify a monogenic cause. Prioritized variants were rated according to the recommendations of the American College of Medical Genetics and Genomics and the Association for Clinical Genomic Science. Diagnostic yields of different phenotypic categories were compared. Clinical data were collected using a standardized questionnaire. In the study cohort, 7/86 individuals had a (likely) pathogenic variant in the genes PAX2, PBX1, EYA1, or SALL1. Additionally, in one individual, a 17q12 deletion syndrome (including HNF1B) was detected. 64 individuals had a kidney affection, which was bilateral in 36. All solved cases (8/86, 9%) had bilateral kidney affection (diagnostic yield in subcohort: 8/36, 22%). Although the diagnostic yield in CAKUT cohorts is low, our single-center experience argues, that, in individuals with bilateral kidney affection, monogenic burden is higher than in those with unilateral kidney or only urinary tract affection. © 2023, The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Exome sequencing in individuals with congenital anomalies of the kidney and urinary tract (CAKUT): a single-center experience(2023) ;Riedhammer, Korbinian M. (57200625458) ;Ćomić, Jasmina (57896737200) ;Tasic, Velibor (7003911066) ;Putnik, Jovana (14008113300) ;Abazi-Emini, Nora (57896737400) ;Paripovic, Aleksandra (35311948800) ;Stajic, Natasa (6602606131) ;Meitinger, Thomas (57215631099) ;Nushi-Stavileci, Valbona (57193881397) ;Berutti, Riccardo (24483074500) ;Braunisch, Matthias C. (57192699344)Hoefele, Julia (57196082805)Individuals with congenital anomalies of the kidney and urinary tract (CAKUT) show a broad spectrum of malformations. CAKUT can occur in an isolated fashion or as part of a syndromic disorder and can lead to end-stage kidney failure. A monogenic cause can be identified in ~12% of affected individuals. This study investigated a single-center CAKUT cohort analyzed by exome sequencing (ES). Emphasis was placed on the question whether diagnostic yield differs between certain CAKUT phenotypes (e.g., bilateral kidney affection, unilateral kidney affection or only urinary tract affection). 86 unrelated individuals with CAKUT were categorized according to their phenotype and analyzed by ES to identify a monogenic cause. Prioritized variants were rated according to the recommendations of the American College of Medical Genetics and Genomics and the Association for Clinical Genomic Science. Diagnostic yields of different phenotypic categories were compared. Clinical data were collected using a standardized questionnaire. In the study cohort, 7/86 individuals had a (likely) pathogenic variant in the genes PAX2, PBX1, EYA1, or SALL1. Additionally, in one individual, a 17q12 deletion syndrome (including HNF1B) was detected. 64 individuals had a kidney affection, which was bilateral in 36. All solved cases (8/86, 9%) had bilateral kidney affection (diagnostic yield in subcohort: 8/36, 22%). Although the diagnostic yield in CAKUT cohorts is low, our single-center experience argues, that, in individuals with bilateral kidney affection, monogenic burden is higher than in those with unilateral kidney or only urinary tract affection. © 2023, The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation(2006) ;Hartig, Monika B. (12144454300) ;Hörtnagel, Konstanze (59867854200) ;Garavaglia, Barbara (7004612048) ;Zorzi, Giovanna (6603821807) ;Kmiec, Tomasz (6603716368) ;Klopstock, Thomas (6603746477) ;Rostasy, Kevin (55938543700) ;Svetel, Marina (6701477867) ;Kostic, Vladimir S. (35239923400) ;Schuelke, Markus (6701679466) ;Botz, Evelyn (8343207700) ;Weindl, Adolf (7005215115) ;Novakovic, Ivana (6603235567) ;Nardocci, Nardo (7003319824) ;Prokisch, Holger (6603080105)Meitinger, Thomas (57215631099)Objective: Neurodegeneration with brain iron accumulation (NBIA) is a group of disorders characterized by magnetic resonance imaging (MRI) changes in basal ganglia. Both missense and nonsense mutations have been found in such patients in a gene encoding the mitochondrial pantothenate kinase (PANK2). Methods: We completed a mutation screen in 72 patients with the diagnosis NBIA based on clinical findings and radiological imaging. The entire coding region of the PANK2 gene (20p12.3) was investigated for point mutations and deletions. Results: We uncovered both mutant alleles in 48 patients. Deletions accounted for 4% of mutated alleles. Patients with two loss-of-function alleles (n = 11) displayed symptoms always at an early stage of life. In the presence of missense mutations (n = 37), the age of onset correlated with residual activity of the pantothenate kinase. Progression of disease measured by loss of ambulation was variable in both groups. We did not observe a strict correlation between the eye-of-the-tiger sign and PANK2 mutations. In 24 patients, no PANK2 mutation was identified. Interpretation: Deletion screening of PANK2 should be part of the diagnostic spectrum. Factors other than enzymatic residual activity are determining the course of disease. There are strong arguments in favor of locus heterogeneity. © 2006 American Neurological Association. - Some of the metrics are blocked by yourconsent settings
Publication Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation(2006) ;Hartig, Monika B. (12144454300) ;Hörtnagel, Konstanze (59867854200) ;Garavaglia, Barbara (7004612048) ;Zorzi, Giovanna (6603821807) ;Kmiec, Tomasz (6603716368) ;Klopstock, Thomas (6603746477) ;Rostasy, Kevin (55938543700) ;Svetel, Marina (6701477867) ;Kostic, Vladimir S. (35239923400) ;Schuelke, Markus (6701679466) ;Botz, Evelyn (8343207700) ;Weindl, Adolf (7005215115) ;Novakovic, Ivana (6603235567) ;Nardocci, Nardo (7003319824) ;Prokisch, Holger (6603080105)Meitinger, Thomas (57215631099)Objective: Neurodegeneration with brain iron accumulation (NBIA) is a group of disorders characterized by magnetic resonance imaging (MRI) changes in basal ganglia. Both missense and nonsense mutations have been found in such patients in a gene encoding the mitochondrial pantothenate kinase (PANK2). Methods: We completed a mutation screen in 72 patients with the diagnosis NBIA based on clinical findings and radiological imaging. The entire coding region of the PANK2 gene (20p12.3) was investigated for point mutations and deletions. Results: We uncovered both mutant alleles in 48 patients. Deletions accounted for 4% of mutated alleles. Patients with two loss-of-function alleles (n = 11) displayed symptoms always at an early stage of life. In the presence of missense mutations (n = 37), the age of onset correlated with residual activity of the pantothenate kinase. Progression of disease measured by loss of ambulation was variable in both groups. We did not observe a strict correlation between the eye-of-the-tiger sign and PANK2 mutations. In 24 patients, no PANK2 mutation was identified. Interpretation: Deletion screening of PANK2 should be part of the diagnostic spectrum. Factors other than enzymatic residual activity are determining the course of disease. There are strong arguments in favor of locus heterogeneity. © 2006 American Neurological Association. - Some of the metrics are blocked by yourconsent settings
Publication The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy—A human genetics department experience(2022) ;Ćomić, Jasmina (57896737200) ;Riedhammer, Korbinian M. (57200625458) ;Günthner, Roman (6507490502) ;Schaaf, Christian W. (59886124500) ;Richthammer, Patrick (23983315500) ;Simmendinger, Hannes (57897933000) ;Kieffer, Donald (57897456500) ;Berutti, Riccardo (24483074500) ;Tasic, Velibor (7003911066) ;Abazi-Emini, Nora (57896737400) ;Nushi-Stavileci, Valbona (57193881397) ;Putnik, Jovana (14008113300) ;Stajic, Nataša (6602606131) ;Lungu, Adrian (35812503300) ;Gross, Oliver (21934239600) ;Renders, Lutz (6602849386) ;Heemann, Uwe (26643385000) ;Braunisch, Matthias C. (57192699344) ;Meitinger, Thomas (57215631099)Hoefele, Julia (57196082805)Disease-causing variants in COL4A3-5 are associated with type-IV-collagen-related nephropathy, a genetically and phenotypically multifaceted disorder comprising Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) and autosomal, X-linked and a proposed digenic inheritance. Initial symptoms of individuals with AS are microscopic hematuria followed by proteinuria leading to kidney failure (90% on dialysis < age 40 years). In contrast, individuals with TBMN, an outdated histology-derived term, present with microscopic hematuria, only some of them develop kidney failure (>50 years of age). An early diagnosis of type-IV-collagen-related nephropathy is essential for optimized therapy and slowing of the disease. Sixty index cases, in whom exome sequencing had been performed and with disease-causing variant(s) in COL4A3-5, were evaluated concerning their clinical tentative diagnosis and their genotype. Of 60 reevaluated individuals with type-IV-collagen-related nephropathy, 72% had AS, 23% TBMN and 5% focal segmental glomerulosclerosis (FSGS) as clinical tentative diagnosis. The FSGS cases had to be re-classified as having type-IV-collagen-related nephropathy. Twelve percent of cases had AS as clinical tentative diagnosis and a monoallelic disease-causing variant in COL4A3/4 but could not be classified as autosomal dominant AS because of limited or conflicting clinical data. This study illustrates the complex clinical and genetic picture of individuals with a type IV-collagen-related nephropathy indicating the need of a refined nomenclature and the more interdisciplinary teamwork of clinicians and geneticists as the key to optimized patient care. Copyright © 2022 Ćomić, Riedhammer, Günthner, Schaaf, Richthammer, Simmendinger, Kieffer, Berutti, Tasic, Abazi-Emini, Nushi-Stavileci, Putnik, Stajic, Lungu, Gross, Renders, Heemann, Braunisch, Meitinger and Hoefele.
